𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Kaposi sarcoma : Appraisal of therapeutic agents

✍ Scribed by Liron Pantanowitz


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
51 KB
Volume
112
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Despite major advancements, the optimal treatment for Kaposi sarcoma has yet to be defined. Comparable standards employing existing therapies to satisfactorily manage all epidemiologic forms of Kaposi sarcoma, and the utilization of mechanism‐based therapeutic strategies with innovative surrogate endpoints to appraise their efficacy, are required.


πŸ“œ SIMILAR VOLUMES


Treatment of kaposi's sarcoma with vinbl
✍ Edmund Klein; Robert Allen Schwartz; Yona Laor; Halina Milgrom; Gordon H. Burges πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 453 KB πŸ‘ 2 views
Classical Kaposi sarcoma : Prognostic fa
✍ Baruch Brenner; Alina Weissmann-Brenner; Erica Rakowsky; Sara Weltfriend; Eyal F πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 87 KB

## Background: Classical kaposi sarcoma (cks) is a rare indolent neoplasm that is particularly prevalent among jews of ashkenazi and mediterranean origin. data regarding prognostic factors for cks are scarce. the aim of the current retrospective analysis was to better define prognostic subgroups am

Association of Kaposi's sarcoma and prio
✍ OlbjΓΈrn Klepp; Olav Dahl; Jan Trygve Stenwig πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 2 views

A retrospective study of 53 cases with a tistological diagnosis of Kaposi's sarcoma (KS) reported to The Cancer Registry of Norway during a five year period is presented. Four cases were excluded from the material because further information contradicted the diagnosis of KS. Of the remaining 49 case

Risk of second cancers in classical Kapo
✍ Henrik Hjalgrim; Morten Frisch; Eero Pukkala; Hrafn Tulinius; Anders Ekbom; Mich πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 39 KB πŸ‘ 2 views

An association between Kaposi's sarcoma (KS) and malignant lymphoma has been suspected for many years. Both cancers belong to the group of malignancies associated with immune suppression and have been known to occur in the same individual. Accordingly, a common etiology has been suspected. Through l